Private Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $5.51M | Sell |
94,957
-15,454
| -14% | -$947K | 1.29% | 22 |
|
|
2023
Q2 | $7.06M | Sell |
110,411
-26,924
| -20% | -$1.81M | 1.36% | 20 |
|
|
2023
Q1 | $9.52M | Sell |
137,335
-4,414
| -3% | -$311K | 1.57% | 18 |
|
|
2022
Q4 | $10.2M | Sell |
141,749
-3,169
| -2% | -$239K | 1.73% | 18 |
|
|
2022
Q3 | $10.3M | Sell |
144,918
-2,945
| -2% | -$214K | 1.82% | 17 |
|
|
2022
Q2 | $11.4M | Sell |
147,863
-3,250
| -2% | -$248K | 1.85% | 17 |
|
|
2022
Q1 | $11M | Sell |
151,113
-10,250
| -6% | -$688K | 1.5% | 19 |
|
|
2021
Q4 | $10.1M | Sell |
161,363
-99
| -0.1% | -$5.81K | 1.24% | 23 |
|
|
2021
Q3 | $9.55M | Sell |
161,462
-2,830
| -2% | -$186K | 1.3% | 23 |
|
|
2021
Q2 | $11M | Buy |
164,292
+1,103
| +0.7% | +$71.9K | 1.46% | 20 |
|
|
2021
Q1 | $10.3M | Buy |
163,189
+706
| +0.4% | +$43.9K | 1.44% | 21 |
|
|
2020
Q4 | $10.1M | Buy |
162,483
+3,727
| +2% | +$229K | 1.51% | 20 |
|
|
2020
Q3 | $9.57M | Buy |
158,756
+15,945
| +11% | +$960K | 1.59% | 20 |
|
|
2020
Q2 | $8.4M | Sell |
142,811
-1,565
| -1% | -$93.6K | 1.49% | 22 |
|
|
2020
Q1 | $8.05M | Buy |
144,376
+16,145
| +13% | +$987K | 1.69% | 20 |
|
|
2019
Q4 | $8.23M | Sell |
128,231
-2,304
| -2% | -$132K | 1.34% | 23 |
|
|
2019
Q3 | $6.62M | Buy |
130,535
+1,246
| +1% | +$58.6K | 1.15% | 32 |
|
|
2019
Q2 | $5.86M | Buy |
129,289
+6,775
| +6% | +$316K | 1% | 34 |
|
|
2019
Q1 | $5.84M | Buy |
122,514
+5,179
| +4% | +$258K | 1.04% | 35 |
|
|
2018
Q4 | $6.1M | Sell |
117,335
-19,479
| -14% | -$1.05M | 1.18% | 28 |
|
|
2018
Q3 | $8.49M | Sell |
136,814
-2,325
| -2% | -$138K | 1.34% | 24 |
|
|
2018
Q2 | $7.7M | Sell |
139,139
-12,601
| -8% | -$681K | 1.24% | 26 |
|
|
2018
Q1 | $9.6M | Sell |
151,740
-16,541
| -10% | -$1.06M | 1.64% | 21 |
|
|
2017
Q4 | $10.3M | Sell |
168,281
-26,134
| -13% | -$1.63M | 1.64% | 21 |
|
|
2017
Q3 | $12.4M | Buy |
194,415
+2,687
| +1% | +$157K | 2% | 17 |
|
|
2017
Q2 | $10.7M | Buy |
191,728
+6,235
| +3% | +$339K | 1.72% | 21 |
|
|
2017
Q1 | $10.1M | Buy |
185,493
+4,745
| +3% | +$260K | 1.64% | 22 |
|
|
2016
Q4 | $10.6M | Buy |
180,748
+1,657
| +0.9% | +$90.6K | 1.76% | 17 |
|
|
2016
Q3 | $9.66M | Buy |
179,091
+11,135
| +7% | +$715K | 1.62% | 20 |
|
|
2016
Q2 | $12.4M | Sell |
167,956
-3,575
| -2% | -$253K | 2.17% | 12 |
|
|
2016
Q1 | $11M | Sell |
171,531
-380
| -0.2% | -$24K | 1.99% | 17 |
|
|
2015
Q4 | $11.8M | Sell |
171,911
-2,850
| -2% | -$188K | 2.14% | 14 |
|
|
2015
Q3 | $10.3M | Sell |
174,761
-3,878
| -2% | -$246K | 1.93% | 18 |
|
|
2015
Q2 | $11.9M | Buy |
178,639
+797
| +0.4% | +$52.5K | 2% | 17 |
|
|
2015
Q1 | $11.5M | Sell |
177,842
-925
| -0.5% | -$57.9K | 1.87% | 17 |
|
|
2014
Q4 | $10.6M | Sell |
178,767
-2,033
| -1% | -$115K | 1.68% | 19 |
|
|
2014
Q3 | $9.25M | Buy |
180,800
+33,937
| +23% | +$1.7M | 1.48% | 23 |
|
|
2014
Q2 | $7.12M | Buy |
146,863
+7,082
| +5% | +$349K | 1.15% | 31 |
|
|
2014
Q1 | $7.26M | Sell |
139,781
-762
| -0.5% | -$40.5K | 1.22% | 30 |
|
|
2013
Q4 | $7.47M | Sell |
140,543
-1,650
| -1% | -$84.1K | 1.29% | 27 |
|
|
2013
Q3 | $6.58M | Sell |
142,193
-8,588
| -6% | -$377K | 1.26% | 27 |
|
|
2013
Q2 | $6.74M | Buy |
+150,781
| New | +$6.55M | 1.29% | 22 |
|
Other funds holding BMY
Private Asset Management's BMY Position: Q3 2023 in Review
Private Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q3 2023, selling an estimated $947K and leaving 94,957 shares worth $5.51M. The position accounts for 1.29% of the portfolio, ranked #22.
Private Asset Management first reported a position in BMY in Q2 2013 and has held it in 42 quarters since. The position peaked at $12.4M in Q3 2017. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Private Asset Management held 94,957 shares of Bristol-Myers Squibb worth $5.51M as of Q3 2023.
- Private Asset Management sold 15,454 Bristol-Myers Squibb shares in Q3 2023, an estimated $947K.
- Bristol-Myers Squibb made up 1.29% of Private Asset Management's portfolio in Q3 2023, its #22 holding.
- Private Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 42 quarters since.
- Private Asset Management's Bristol-Myers Squibb position peaked at $12.4M in Q3 2017.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Private Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.